Skip to main content
. 2019 Jul 10;10:1595. doi: 10.3389/fmicb.2019.01595

TABLE 1.

Sequencing data and the alpha diversity in each group of mice.

Items C DSS Cecropin A Genta SEM
OS 522a 439b 501a 472ab 10
Shannon 6.2073a 5.2736b 5.8118a 5.8738a 0.10
Simpson 0.9691a 0.9255b 0.9605a 0.9495ab 0.05
Chao1 508.51a 459.98b 507.17a 490.37ab 10.89
ACE 539.18a 458.83c 519.22a 490.51b 10.55

Control: the control group (n = 9); Gentamicin: the mice was pretreated by using 2.5% DSS for 5 days and then intraperitoneal inject 5 mg/kg body weight gentamicin (n = 8). Cecropin A: the mice were pretreated by using 2.5% DSS for 5 days and then received intraperitoneal injection of 15 mg/kg body weight cecropin A (n = 9). DSS: The mice treated by 2.5% DSS (n = 7). The control group and DSS group received intraperitoneal injection of saline. The data were shown as mean ± SEM and when significant main effects or interactive effects were observed, the means were compared using the least significant difference (LSD) method. P < 0.05 were taken to indicate statistical significance between groups. Means with different letters “a” (the groups with highest level), “b” (the middle level”) and “c” (the lowest level)” are significantly different. OS, observed species; ACE, abundance-based coverage estimator.